Search Results - "Hölig, K"

Refine Results
  1. 1

    CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function by Jing, D, Oelschlaegel, U, Ordemann, R, Hölig, K, Ehninger, G, Reichmann, H, Ziemssen, T, Bornhäuser, M

    Published in Bone marrow transplantation (Basingstoke) (01-10-2010)
    “…Therapeutic application of natalizumab, an anti-CD49d Ab, in patients with multiple sclerosis (MS) has been associated with increased levels of circulating…”
    Get full text
    Journal Article
  2. 2

    Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation by Ringdén, O., Remberger, M., Runde, V., Bornhäuser, M., Blau, I.W., Basara, N., Hölig, K., Beelen, D.W., Hägglund, H., Basu, O., Ehninger, G., Fauser, A.A.

    Published in Blood (15-07-1999)
    “…Peripheral blood stem cell (PBSC) transplants from HLA-A, -B, and -DR compatible unrelated donors (n = 45) were compared with bone marrow (BM; BM group, n =…”
    Get full text
    Journal Article
  3. 3
  4. 4

    CD34+‐enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add‐back by Bornhäuser, Martin, Platzbecker, Uwe, Theuser, Catrin, Hölig, K., Ehninger, Gerhard

    Published in British journal of haematology (01-09-2002)
    “…Fifty‐one adults with haematological malignancies were transplanted with CD34+‐selected peripheral blood progenitor cells (PBPC) from unrelated donors. The…”
    Get full text
    Journal Article
  5. 5

    Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium by von Bonin, M, Stölzel, F, Goedecke, A, Richter, K, Wuschek, N, Hölig, K, Platzbecker, U, Illmer, T, Schaich, M, Schetelig, J, Kiani, A, Ordemann, R, Ehninger, G, Schmitz, M, Bornhäuser, M

    Published in Bone marrow transplantation (Basingstoke) (01-02-2009)
    “…Mesenchymal stem cells have been shown to mediate immunomodulatory effects. They have been used in patients with steroid-refractory acute GVHD (aGVHD), but…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Rapid engraftment after allogeneic ABO-incompatible peripheral blood progenitor cell transplantation complicated by severe hemolysis by BORNHÄUSER, M, ORDEMANN, R, PAAZ, U, SCHULER, U, KÖMPF, J, HÖLIG, K, EHNINGER, G

    Published in Bone marrow transplantation (Basingstoke) (01-02-1997)
    “…A patient with CML in accelerated phase received G-CSF-mobilized PBPC from an unrelated HLA genotypically matched donor. The blood groups of the patient and…”
    Get full text
    Journal Article
  8. 8

    Methodological and clinical aspects of alloimmunization after granulocyte transfusion in patients undergoing allogeneic stem cell transplantation by Flaxa, J., Rosner, A., Hölig, K., Bornhäuser, M., Wassmuth, R.

    Published in Tissue antigens (01-02-2015)
    “…In allogeneic hematopoietic stem cell transplantation (HSCT), granulocyte transfusions (GT) may be required in immunocompromised, neutropenic patients. In this…”
    Get full text
    Journal Article
  9. 9

    Acceptance and feasibility of peripheral stem cell mobilisation compared to bone marrow collection from healthy unrelated donors by Ordemann, R, Hölig, K, Wagner, K, Rautenberg, U, Bornhäuser, M, Kroschinsky, F, Schäfer, J, Schuler, U, Ehninger, G

    Published in Bone marrow transplantation (Basingstoke) (01-06-1998)
    “…Allogeneic peripheral blood stem cell transplantation leads to an earlier engraftment compared to BMT. The feasibility, acceptance and long-term side-effects…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Successful treatment of acquired hemophilia A with recombinant porcine factor VIII by Trautmann-Grill, K, Tiebel, O, Hölig, K, Platzbecker, U

    “…Acquired hemophilia A is a rare, potentially life-threatening disease resulting from autoantibodies against coagulation factor VIII. We report the case of…”
    Get full text
    Journal Article
  12. 12

    Experiences of the Dresdner Cord Blood Bank, supported by the Deutsche Knochenmarkspenderdatei by Ordemann, R, Petzold, K, Hölig, K, Schaffer, B, Mauersberger, S, Ehninger, G, Ehminger, G

    Published in Seminars in thrombosis and hemostasis (01-01-1999)
    “…Allogeneic bone marrow and peripheral blood stem cell transplantation is the treatment of choice for some malignant hematologic diseases, marrow failure…”
    Get more information
    Journal Article
  13. 13

    Peripheral blood stem cell transplantation from unrelated donors : A comparison with marrow transplantation by RINGDEN, O, REMBERGER, M, EHNINGER, G, FAUSER, A. A, RUNDE, V, BORNHÄUSER, M, BLAU, I. W, BASARA, N, HÖLIG, K, BEELEN, D. W, HÄGGLUND, H, BASU, O

    Published in Blood (15-07-1999)
    “…Peripheral blood stem cell (PBSC) transplants from HLA-A, -B, and -DR compatible unrelated donors (n = 45) were compared with bone marrow (BM; BM group, n =…”
    Get full text
    Journal Article
  14. 14

    Spleen enlargement in healthy donors during G-CSF mobilization of PBPCs by Platzbecker, Uwe, Prange-Krex, Gabriele, Bornhäuser, Martin, Koch, Rainer, Soucek, Silke, Aikele, Peter, Haack, Astrid, Haag, Cornelie, Schuler, Ulrich, Berndt, Anette, Rutt, Claudia, Ehninger, Gerhard, Hölig, Kristina

    Published in Transfusion (Philadelphia, Pa.) (01-02-2001)
    “…BACKGROUND: Recombinant human G–CSF is widely used to mobilize PBPCs in healthy donors for allogeneic transplantation. There have been concerns about donor…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation by Ringdén, O, Remberger, M, Runde, V, Bornhäuser, M, Blau, I W, Basara, N, Hölig, K, Beelen, D W, Hägglund, H, Basu, O, Ehninger, G, Fauser, A A

    Published in Bone marrow transplantation (Basingstoke) (01-05-2000)
    “…Engraftment was achieved in 43/45 (95%) recipients of peripheral blood stem cells (PBSC) from HLA-compatible unrelated donors (n = 45), compared to all 45…”
    Get full text
    Journal Article Conference Proceeding
  17. 17
  18. 18

    Erfolgreiche Behandlung einer erworbenen Hemmkörperhämophilie A mit rekombinantem porcinem Faktor VIII by Trautmann-Grill, K., Tiebel, O., Hölig, K., Platzbecker, U.

    “…Zusammenfassung Die erworbene Hemmkörperhämophilie A ist eine seltene, lebensbedrohliche hämorrhagische Diathese, bedingt durch Autoantikörperbildung gegen…”
    Get full text
    Journal Article
  19. 19

    Influence of packed red cell transfusions on blood selenium concentration in pediatric hemato-oncology by Mackenroth, J, Hölig, K, Kuhlisch, E, Siegert, G, Suttorp, M

    Published in Klinische Pädiatrie (01-05-2008)
    “…In humans approx. 10% of the total body selenium (Se) content is present in the blood being evenly distributed among plasma and red cells. The important role…”
    Get more information
    Journal Article
  20. 20

    Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis by Bornhauser, M, Theuser, C, Soucek, S, Holig, K, Klingebiel, T, Blau, W, Fauser, A, Runde, V, Schwinger, W, Rutt, C, Ehninger, G

    Published in Haematologica (Roma) (01-08-2000)
    “…Med. Klinik I, Universit tsklinikum Carl Gustav Carus, Fetscherstrasse 74, 01307 Dresden, Germany. bornhaeuser@oncocenter.de BACKGROUND AND OBJECTIVES:…”
    Get full text
    Journal Article